Evidence map›Paper›PMID 29449847›Full record

ReviewFrontiers in immunology2018

Potential Epigenetic Regulation in the Germinal Center Reaction of Lymphoid Tissues in HIV/SIV Infection.

Xiaolei Wang, Huanbin Xu

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Abnormal Tryptophan Metabolism in HIV andFrontiers in microbiology · 2021
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaolei WangTulane National Primate Research Center, Tulane University School of Medicine, Covington, LA, United States.
Huanbin XuTulane National Primate Research Center, Tulane University School of Medicine, Covington, LA, United States.

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Novel strategies for eliminating HIV reservoirs in lymphoid tissuesR01DE025432 · NIDCR · TULANE UNIVERSITY OF LOUISIANA · PI XU, HUANBIN · 2015 to 2019
$4.0M
Development of the neonatal mucosal immune system in nonhuman primatesR01AI099795 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI WANG, XIAOLEI · 2012 to 2016
$2.9M
NIAID NIH HHS R01 AI099795NIDCR NIH HHS R01 DE025432NIH HHS P51 OD011104
6 · The paper itself

Abstract

The production of high-affinity and broadly neutralizing antibodies plays a key role in the defense against pathogens. These antibody responses require effective germinal center (GC) reaction within anatomical niches of GCs, where follicular helper T (Tfh) cells provide cognate help to B cells for T cell-dependent antibody responses. Emerging evidences indicate that GC reaction in normal state and perhaps establishment of latent Tfh cell reservoir in HIV/SIV infection are tightly regulated by epigenetic histone modifications, which are responsible for activating or silencing chromatin. A better understanding of the mechanisms behind GC responses at cellular and molecular levels thus provides necessary knowledge for vaccination and immunotherapy. In this review, we discussed the epigenetic regulation of GC responses, especially for GC B and Tfh cell under normal state or HIV/SIV infection.

Indexed as

Epigenesis, GeneticGene Expression RegulationAnimalsAntibodies, NeutralizingB-LymphocytesCD4-Positive T-LymphocytesGerminal CenterHistone CodeHIV InfectionsLymphoid TissueMacaca mulattaMiceSimian Acquired Immunodeficiency SyndromeAntibodies, NeutralizingB cellsEpigenectic regulationfollicular CD4 T helper cellsgerminal center reactionsHIV

Identifiers

PMID29449847
PMCPMC5799247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.